In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NascaCell GmbH

Executive Summary

NascaCell GmbH, a German start-up founded in 2000, is using aptamer technology to gain new perspectives on drug discovery. The company uses its RNA-based Nucleic Acid Biotool robotics platform to combine target validation and small molecule screening to speed up drug discovery.
Advertisement

Related Content

No Nonsense Drug Discovery
Protein Arrays: When Genes Are Not Enough

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004639

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel